Breaking News Instant updates and real-time market news.

NTRA

Natera

$38.94

0.42 (1.09%)

07:28
11/04/19
11/04
07:28
11/04/19
07:28

Natera price target raised to $32 from $27 at JPMorgan

JPMorgan analyst Tycho Peterson raised his price target for Natera to $32 from $27 after completing a survey on the U.S. kidney transplant rejection monitoring market. He says that given the recent excitement around liquid biopsy and Natera's Signatera test for recurrence monitoring, he now believes Prospera is an underappreciated opportunity for the company in investor estimates. Peterson keeps a Neutral rating on Natera shares.

  • 06

    Nov

NTRA Natera
$38.94

0.42 (1.09%)

09/24/19
PIPR
09/24/19
NO CHANGE
Target $45
PIPR
Overweight
Natera price target raised to $45 from $32 at Piper Jaffray
Piper Jaffray analyst William Quirk said Natera's partnership with Foundation Medicine for the Signatera assay complements Natera's own direct channels and broadens the utility of the assay to late stage cancers. The analyst, who also thinks the deal increases Natera's access to large customer groups, increased his price target on Natera shares to $45 from $32 and keeps an Overweight rating on the stock.
10/11/19
PIPR
10/11/19
NO CHANGE
Target $45
PIPR
Overweight
Natera oncology opportunity 'remains strong,' says Piper Jaffray
Piper Jaffray analyst William Quirk keeps an Overweight rating on Natera with a $45 price target after the company hosted a conference call to discuss its oncology offering. Management has a clear plan to access the oncology market via partnerships with Foundation Medicine and BGI, and their own direct channels, Quirk tells investors in a research note partially titled "Oncology Opportunity Remains Strong". The analyst estimates the initial Signatera market opportunity for colorectal cancer is ~$4.4B. While smaller than his initial expectations, Quirk continues to believe the long-term opportunity "remains robust" as Natera expands the assay to other cancers and gains traction with clinical and pharma customers.
10/18/19
COWN
10/18/19
NO CHANGE
Target $42
COWN
Outperform
Natera price target raised to $42 from $30 at Cowen
Cowen analyst Doug Schenkel raised his price target on Natera to $42 from $30 following the company's preannouncement of Q3 results which were ahead of expectations. The analyst updated his model to account for recent positive developments, updates on Signatera and Prospera, and to take a more conservative outlook for average-risk NIPT. Schenkel reiterated his Outperform rating on Natera shares.
10/22/19
PIPR
10/22/19
NO CHANGE
Target $45
PIPR
Overweight
Natera has 'significant opportunity' in oncology, says Piper Jaffray
Piper Jaffray analyst William Quirk estimates Natera has a $12.8B market opportunity for Signatera in bladder, breast, colon, and lung cancer. This is somewhat comparable with management's $15B estimate of the oncology molecular residual disease market opportunity, Quirk tells investors in a research note. The analyst continues to believe oncology represents a "significant opportunity" for Natera. He reiterates an Overweight rating on the shares with a $45 price target.

TODAY'S FREE FLY STORIES

THS

TreeHouse

$50.86

0.155 (0.31%)

08:08
12/06/19
12/06
08:08
12/06/19
08:08
Conference/Events
TreeHouse to host investor meeting »

Investor breakfast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PSMT

PriceSmart

$74.03

1.095 (1.50%)

08:08
12/06/19
12/06
08:08
12/06/19
08:08
Hot Stocks
PriceSmart opens new warehouse club in Guatemala City, Guatemala »

PriceSmart announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSMT

PriceSmart

$74.03

1.095 (1.50%)

08:07
12/06/19
12/06
08:07
12/06/19
08:07
Hot Stocks
PriceSmart reports November net merchandise sales up 7.5% to $278.3M »

PriceSmart announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$17.20

0.05 (0.29%)

08:06
12/06/19
12/06
08:06
12/06/19
08:06
Hot Stocks
Kratos awarded $39M sole-source contract for RF signal communication services »

Kratos Defense &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JILL

J.Jill

$1.22

-0.49 (-28.66%)

08:06
12/06/19
12/06
08:06
12/06/19
08:06
Downgrade
J.Jill rating change  »

Jefferies downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZUL

Azul

$38.17

0.33 (0.87%)

08:05
12/06/19
12/06
08:05
12/06/19
08:05
Hot Stocks
Azul reports November traffic up 30.6%, capacity up 32.5% »

Load factor was 82.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FGP

Ferrellgas Partners

$0.57

-0.024 (-4.07%)

08:04
12/06/19
12/06
08:04
12/06/19
08:04
Earnings
Ferrellgas Partners reports Q1 EPS (46c), one est. (35c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SATS

EchoStar

$39.76

0.36 (0.91%)

08:03
12/06/19
12/06
08:03
12/06/19
08:03
Hot Stocks
Yahsat and Hughes launch satellite services joint venture in Brazil »

Hughes Network Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHAT

Blue Hat Interactive

$2.72

-0.01 (-0.37%)

08:02
12/06/19
12/06
08:02
12/06/19
08:02
Hot Stocks
Blue Hat signs LOI to acquire controlling interest in Fuzhou Csfctech Co. »

Blue Hat Interactive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOME

At Home Group

$5.48

-3.07 (-35.91%)

08:02
12/06/19
12/06
08:02
12/06/19
08:02
Downgrade
At Home Group rating change  »

At Home Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$16.62

0.065 (0.39%)

08:01
12/06/19
12/06
08:01
12/06/19
08:01
Recommendations
Yext analyst commentary  »

Yext price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$106.80

-0.48 (-0.45%)

08:01
12/06/19
12/06
08:01
12/06/19
08:01
Hot Stocks
Post Holdings announces new $400M share repurchase authorization »

Post Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIN

Albany International

$81.66

-1.04 (-1.26%)

, EADSY

Airbus

$0.00

(0.00%)

08:01
12/06/19
12/06
08:01
12/06/19
08:01
Hot Stocks
Albany International subsidiary signs two-year research agreement with Airbus »

Albany International…

AIN

Albany International

$81.66

-1.04 (-1.26%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$119.18

-2.64 (-2.17%)

08:01
12/06/19
12/06
08:01
12/06/19
08:01
Recommendations
Okta analyst commentary  »

Okta price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

ENB

Enbridge

$38.50

0.235 (0.61%)

08:00
12/06/19
12/06
08:00
12/06/19
08:00
Conference/Events
Enbridge to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PD

PagerDuty

$24.99

-0.66 (-2.57%)

08:00
12/06/19
12/06
08:00
12/06/19
08:00
Recommendations
PagerDuty analyst commentary  »

PagerDuty price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRXC

TransEnterix

$0.19

-0.0003 (-0.16%)

07:59
12/06/19
12/06
07:59
12/06/19
07:59
Conference/Events
TransEnterix to hold a webcast »

Management hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 18

    Dec

TDOC

Teladoc

$79.34

-0.71 (-0.89%)

07:57
12/06/19
12/06
07:57
12/06/19
07:57
Downgrade
Teladoc rating change  »

Jefferies downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

07:57
12/06/19
12/06
07:57
12/06/19
07:57
Recommendations
Zoom Video analyst commentary  »

JPMorgan sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

YEXT

Yext

$16.62

0.065 (0.39%)

07:55
12/06/19
12/06
07:55
12/06/19
07:55
Recommendations
Yext analyst commentary  »

Yext price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$104.68

-0.49 (-0.47%)

07:55
12/06/19
12/06
07:55
12/06/19
07:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Task Force on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQN

Algonquin Power

$14.35

0.05 (0.35%)

07:55
12/06/19
12/06
07:55
12/06/19
07:55
Conference/Events
Algonquin Power to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

IFF

International Flavors

$141.82

1.8 (1.29%)

07:53
12/06/19
12/06
07:53
12/06/19
07:53
Recommendations
International Flavors analyst commentary  »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

07:53
12/06/19
12/06
07:53
12/06/19
07:53
Initiation
ConocoPhillips initiated  »

ConocoPhillips initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$207.33

2.53 (1.24%)

07:51
12/06/19
12/06
07:51
12/06/19
07:51
Recommendations
CME Group analyst commentary  »

CME Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.